Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Johannes Byrling, Agata Sasor, Johan Nilsson, Katarzyna Said Hilmersson, Roland Andersson & Bodil Andersson. (2020) Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome. Scandinavian Journal of Gastroenterology 55:6, pages 725-731.
Read now
Read now
Daniel Ansari, Maria Carvajo, Monika Bauden & Roland Andersson. (2017) Pancreatic cancer stroma: controversies and current insights. Scandinavian Journal of Gastroenterology 52:6-7, pages 641-646.
Read now
Read now
Articles from other publishers (25)
Yuanting Li, Minghao Chen, Qing Chen, Min Yuan, Xi Zeng, Yan Zeng, Meibo He, Baiqiang Wang & Bin Han. (2023) Bioinformatics Identification of Therapeutic Gene Targets for Gastric Cancer. Advances in Therapy 40:4, pages 1456-1473.
Crossref
Crossref
Xu Zhao, Shuang Wu & Jingjing Jing. (2021) Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing. Pathology and Oncology Research 27.
Crossref
Crossref
Luciana Mosca, Andrea Ilari, Francesco Fazi, Yehuda G. Assaraf & Gianni Colotti. (2021) Taxanes in cancer treatment: Activity, chemoresistance and its overcoming. Drug Resistance Updates 54, pages 100742.
Crossref
Crossref
Daniel Ansari & Roland Andersson. 2021. Textbook of Pancreatic Cancer. Textbook of Pancreatic Cancer
467
487
.
Christopher Hartley, Daniel Rowan, Xiuxu Chen, Luisa Gomez-Arellano, Anna Marie West, Kiyoko Oshima & Alexander Craig Mackinnon. (2020) Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma. Practical Laboratory Medicine 21, pages e00171.
Crossref
Crossref
Seifeldin Awad, Ahmad M. Alkashash, Magi Amin, Samantha J. Baker & J. Bart Rose. (2020) Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 10.
Crossref
Crossref
Yilun Li & Li Ma. (2020) Exposure to solar ultraviolet radiation and breast cancer risk. Medicine 99:45, pages e23105.
Crossref
Crossref
Denise Camacho, Joana P. Jesus, António M. Palma, Sofia A. Martins, Alexandre Afonso, Maria Leonor Peixoto, Christopher J. Pelham, Eduardo Moreno & Rajan Gogna. 2020.
171
199
.
Dingyuan Hu, Daniel Ansari, Qimin Zhou, Agata Sasor, Katarzyna Said Hilmersson & Roland Andersson. (2019) Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma. World Journal of Surgical Oncology 17:1.
Crossref
Crossref
Khusbu Khetan, Vandana Baloda, Ranjit K. Sahoo, Sreenivas Vishnubhathla, Rajni Yadav, Anoop Saraya, Atul Sharma, Siddhartha Datta Gupta & Prasenjit Das. (2019) SPARC expression in desmoplastic and non desmoplastic pancreatic carcinoma and cholangiocarcinoma. Pathology - Research and Practice 215:12, pages 152685.
Crossref
Crossref
Ughur Aghamaliyev, Haristi Gaitantzi, Maria Thomas, Katja Simon-Keller, Timo Gaiser, Alexander Marx, Vugar Yagublu, Joaquin Araos, Chen Cai, Nektarios A. Valous, Niels Halama, Tobias Kiesslich, Matthias Ebert, Robert Grützmann, Felix Rückert & Katja Breitkopf-Heinlein. (2019) Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer Cells. European Surgical Research 60:1-2, pages 1-12.
Crossref
Crossref
Anteneh Tesfaye & Philip A. Philip. 2019. Textbook of Gastrointestinal Oncology. Textbook of Gastrointestinal Oncology
255
268
.
Ozkan Kanat & Hulya Ertas. (2018) Shattering the castle walls: Anti-stromal therapy for pancreatic cancer. World Journal of Gastrointestinal Oncology 10:8, pages 202-210.
Crossref
Crossref
Ryuta Shintakuya, Naru Kondo, Yoshiaki Murakami, Kenichiro Uemura, Naoya Nakagawa, Keisuke Okano, Shinya Takahashi & Taijiro Sueda. (2018) The high stromal SPARC expression is independently associated with poor survival of patients with resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine in combination with S-1 or adjuvant gemcitabine alone. Pancreatology 18:2, pages 191-197.
Crossref
Crossref
Chen Liang, Si Shi, Qingcai Meng, Dingkong Liang, Shunrong Ji, Bo Zhang, Yi Qin, Jin Xu, Quanxing Ni & Xianjun Yu. (2017) Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?. Cellular and Molecular Life Sciences 75:6, pages 1001-1012.
Crossref
Crossref
Sirio Fiorino, Maria Letizia Bacchi-Reggiani, Chiara Birtolo, Giorgia Acquaviva, Michela Visani, Adele Fornelli, Michele Masetti, Andrea Tura, Stefano Sbrignadello, Fabio Grizzi, Federica Patrinicola, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Claudia Benini, Luca Di Tommaso, Arrigo Bondi, Francesco Monetti, Elena Siopis, Paolo Emilio Orlandi, Michele Imbriani, Carlo Fabbri, Silvia Giovanelli, Andrea Domanico, Esterita Accogli, Salomone Di Saverio, Daniela Grifoni, Vincenzo Cennamo, Paolo Leandri, Elio Jovine & Dario de Biase. (2018) Matricellular proteins and survival in patients with pancreatic cancer: A systematic review. Pancreatology 18:1, pages 122-132.
Crossref
Crossref
Daniel Drev, Andrea Bileck, Zeynep N. Erdem, Thomas Mohr, Gerald Timelthaler, Andrea Beer, Christopher Gerner & Brigitte Marian. (2017) Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction. Clinical Proteomics 14:1.
Crossref
Crossref
Yi Gao, Shui-Ping Yin, Xu-Shi Xie, Dan-Dan Xu & Wei-Dong Du. (2017) The relationship between stromal cell derived SPARC in human gastric cancer tissue and its clinicopathologic significance. Oncotarget 8:49, pages 86240-86252.
Crossref
Crossref
Veronique L. Veenstra, Helene Damhofer, Cynthia Waasdorp, Anne Steins, Hemant M. Kocher, Jan P. Medema, Hanneke W. van Laarhoven & Maarten F Bijlsma. (2017) Stromal SPOCK1 supports invasive pancreatic cancer growth. Molecular Oncology 11:8, pages 1050-1064.
Crossref
Crossref
S. Yadavalli, S. Jayaram, S. S. Manda, A. K. Madugundu, D. S. Nayakanti, T. Z. Tan, R. Bhat, A. Rangarajan, A. Chatterjee, H. Gowda, J. P. Thiery & P. Kumar. (2017) Data-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells. Scientific Reports 7:1.
Crossref
Crossref
Steffen Ormanns, Michael Haas, Sibylle Baechmann, Annelore Altendorf-Hofmann, Anna Remold, Detlef Quietzsch, Michael R Clemens, Martin Bentz, Michael Geissler, Helmut Lambertz, Stephan Kruger, Thomas Kirchner, Volker Heinemann & Stefan Boeck. (2016) Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials. British Journal of Cancer 115:12, pages 1520-1529.
Crossref
Crossref
Monica Rossi, Manu Gnanamony & Christopher Gondi. (2016) The ‘SPARC’ of life: Analysis of the role of osteonectin/SPARC in pancreatic cancer (Review). International Journal of Oncology.
Crossref
Crossref
Wei Han, Fang Cao, Min-bin Chen, Rong-zhu Lu, Hua-bing Wang, Min Yu, Chun-tao Shi & Hou-zhong Ding. (2016) Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis. PLOS ONE 11:1, pages e0145803.
Crossref
Crossref
Javier Martinez-Useros & Jesus Garcia-Foncillas. (2016) Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?. BioMed Research International 2016, pages 1-13.
Crossref
Crossref
Stephanie E. Combs. (2015) Individualized radiotherapy (iRT) concepts for locally advanced pancreatic cancer (LAPC): indications and prognostic factors. Langenbeck's Archives of Surgery 400:7, pages 749-756.
Crossref
Crossref